(Bloomberg) -- Life sciences company Danaher Corp. has expressed takeover interest in contract manufacturer Catalent Inc., according to people familiar with the matter. Most Read from Bloomberg ...
When the companies first unveiled their takeover plans, Novo Holdings and Catalent said ... Bloomberg reported back in February of 2023 that life sciences conglomerate Danaher had expressed an ...
(Bloomberg) -- Catalent Inc. shares rose after the troubled contract drug manufacturer gave investors some reassurance about a slashed fiscal full-year outlook and the third delay to its quarterly ...
April 24, 2024 The Takeover Trailer April 24, 2024 • The largest school district in Texas lost its elected leaders in the summer of 2023. In their place – a state-appointed board along with a ...
One of the Columbia University students who bravely tried to stop a mob of anti-Israel protesters from taking over an academic building last night tells Fox News Digital they tried to delay the ...
Pall Corp. (PLL) stock is rising after the company said it will be acquired by Danaher (DHR) for $13.8 billion. Pall Corp. (PLL) stock is rising after the company said it will be acquired by ...
One of the Columbia University students who bravely tried to stop a mob of anti-Israel protesters from taking over an academic building last night tells Fox News Digital they tried to delay the ...
Catalent, Inc. is a holding company, which engages in the provision of delivery technologies, development, and manufacturing solutions for drugs, biologics, cell and gene therapies, and consumer ...
WASHINGTON (AP) — WASHINGTON (AP) — Danaher Corp. (DHR) on Tuesday reported first-quarter profit of $1.09 billion. The Washington-based company said it had net income of $1.45 per share.
No significant news for in the past two years. Key Stock Data P/E Ratio (TTM) The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing ...